• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

二烯丙基二硫与人血清白蛋白的抗淀粉样特性及相互作用。

Anti-amyloidogenic behavior and interaction of Diallylsulfide with Human Serum Albumin.

机构信息

Interdisciplinary Biotechnology Unit, Aligarh Muslim University, Aligarh, 202002, Uttar Pradesh, India.

Interdisciplinary Biotechnology Unit, Aligarh Muslim University, Aligarh, 202002, Uttar Pradesh, India.

出版信息

Int J Biol Macromol. 2016 Nov;92:1220-1228. doi: 10.1016/j.ijbiomac.2016.08.035. Epub 2016 Aug 12.

DOI:10.1016/j.ijbiomac.2016.08.035
PMID:27527697
Abstract

In this work, binding of garlic component-Diallysulfide (DAS) with major human blood transport protein, Human Serum Albumin (HSA) and its anti- amyloidogenic behavior has been studied by utilizing various spectroscopic and molecular docking strategies. The HSA exhibit significant reduction in fluorescence intensity upon interaction with DAS. DAS quenches the fluorescence of HSA in concentration dependent manner with binding affinity of 1.14×10M. UV-visible spectroscopy results confirm the formation of DAS-HSA complex and secondary structure of HSA get stabilized upon complexation with DAS as observed by far UV CD spectroscopy and Differential Scanning Calorimetry. The topology of HSA in absence and presence of DAS was monitored through Dynamic Light Scattering (DLS) technique, inferred that protein becomes more compact in presence of DAS. Further, molecular docking study shows that DAS bind to the nearby site II in subdomain III of HSA. Moreover, effect of DAS was studied on HSA fibrillation process. ThT binding, ANS fluorescence assay, CD measurement, DLS and Transmission Electron Microscopy (TEM) results altogether confirm the anti-amyloidogenic property of DAS. This work will provide biophysical insight into the interaction of DAS with HSA and will help in designing more potential therapeutic strategies against protein aggregation by exploiting other related compounds.

摘要

在这项工作中,利用各种光谱和分子对接策略研究了大蒜成分——二烯丙基二硫(DAS)与人血清白蛋白(HSA)的结合及其抗淀粉样变性行为。HSA 与 DAS 相互作用时,其荧光强度显著降低。DAS 以浓度依赖的方式猝灭 HSA 的荧光,结合亲和力为 1.14×10M。紫外可见光谱结果证实了 DAS-HSA 复合物的形成,远紫外 CD 光谱和差示扫描量热法表明,HSA 的二级结构在与 DAS 络合后得到稳定。通过动态光散射(DLS)技术监测 HSA 在有无 DAS 存在下的拓扑结构,推断出 DAS 存在时蛋白质变得更加紧凑。此外,分子对接研究表明 DAS 结合到 HSA 亚结构域 III 中附近的 II 位点。此外,还研究了 DAS 对 HSA 纤化过程的影响。ThT 结合、ANS 荧光测定、CD 测量、DLS 和透射电子显微镜(TEM)结果共同证实了 DAS 的抗淀粉样变性特性。这项工作将为 DAS 与 HSA 的相互作用提供生物物理见解,并通过利用其他相关化合物为设计更多针对蛋白质聚集的潜在治疗策略提供帮助。

相似文献

1
Anti-amyloidogenic behavior and interaction of Diallylsulfide with Human Serum Albumin.二烯丙基二硫与人血清白蛋白的抗淀粉样特性及相互作用。
Int J Biol Macromol. 2016 Nov;92:1220-1228. doi: 10.1016/j.ijbiomac.2016.08.035. Epub 2016 Aug 12.
2
Biophysical insight into the anti-amyloidogenic behavior of taurine.对牛磺酸抗淀粉样蛋白生成行为的生物物理洞察。
Int J Biol Macromol. 2015 Sep;80:375-84. doi: 10.1016/j.ijbiomac.2015.06.035. Epub 2015 Jun 22.
3
Characterization of the binding of an anticancer drug, lapatinib to human serum albumin.一种抗癌药物拉帕替尼与人血清白蛋白结合的特性研究
J Photochem Photobiol B. 2016 Jul;160:229-39. doi: 10.1016/j.jphotobiol.2016.04.005. Epub 2016 Apr 13.
4
Investigating the site selective binding of busulfan to human serum albumin: Biophysical and molecular docking approaches.研究白消安与人血清白蛋白的位点选择性结合:生物物理和分子对接方法。
Int J Biol Macromol. 2018 Feb;107(Pt B):1414-1421. doi: 10.1016/j.ijbiomac.2017.10.006. Epub 2017 Oct 5.
5
Interaction of meropenem with 'N' and 'B' isoforms of human serum albumin: a spectroscopic and molecular docking study.美罗培南与人血清白蛋白‘N’和‘B’亚型的相互作用:光谱学和分子对接研究
J Biomol Struct Dyn. 2016 Sep;34(9):1849-64. doi: 10.1080/07391102.2015.1094411. Epub 2015 Nov 10.
6
Binding of Janus kinase inhibitor tofacitinib with human serum albumin: multi-technique approach.托法替布这种Janus激酶抑制剂与人血清白蛋白的结合:多技术方法
J Biomol Struct Dyn. 2016 Sep;34(9):2037-44. doi: 10.1080/07391102.2015.1104522. Epub 2016 May 9.
7
Study on the interaction of the epilepsy drug, zonisamide with human serum albumin (HSA) by spectroscopic and molecular docking techniques.运用光谱和分子对接技术研究抗癫痫药物佐尼沙胺与人血清白蛋白(HSA)的相互作用。
Spectrochim Acta A Mol Biomol Spectrosc. 2013 Oct;114:627-32. doi: 10.1016/j.saa.2013.05.092. Epub 2013 Jun 13.
8
Probing the interaction of anticancer drug temsirolimus with human serum albumin: molecular docking and spectroscopic insight.探究抗癌药物替西罗莫司与人血清白蛋白的相互作用:分子对接和光谱学研究。
J Biomol Struct Dyn. 2018 May;36(6):1479-1489. doi: 10.1080/07391102.2017.1326320. Epub 2017 May 18.
9
Investigations with spectroscopy, zeta potential and molecular modeling of the non-cooperative behaviour between cyclophosphamide hydrochloride and aspirin upon interaction with human serum albumin: binary and ternary systems from multi-drug therapy.对盐酸环磷酰胺和阿司匹林与人血清白蛋白相互作用时非协同行为进行光谱学、ζ 电位和分子建模研究:来自多药物治疗的二元和三元体系。
J Biomol Struct Dyn. 2011 Aug;29(1):181-206. doi: 10.1080/07391102.2011.10507382.
10
Fibrillogenesis of human serum albumin in the presence of levodopa - spectroscopic, calorimetric and microscopic studies.左旋多巴存在下人类血清白蛋白的纤维形成——光谱、量热及显微镜研究
Int J Biol Macromol. 2017 Jan;94(Pt A):301-308. doi: 10.1016/j.ijbiomac.2016.10.025. Epub 2016 Oct 12.

引用本文的文献

1
Decoding Solubility Signatures from Amyloid Monomer Energy Landscapes.从淀粉样蛋白单体能量景观中解码溶解度特征
J Chem Theory Comput. 2025 Mar 11;21(5):2736-2756. doi: 10.1021/acs.jctc.4c01623. Epub 2025 Feb 24.
2
Interactions between Human Serum Albumin and Sulfadimethoxine Determined Using Spectroscopy and Molecular Docking.利用光谱学和分子对接技术测定人血清白蛋白与磺胺二甲氧嘧啶之间的相互作用
Molecules. 2022 Feb 24;27(5):1526. doi: 10.3390/molecules27051526.
3
Study on the Interactions Between Caffeoylquinic Acids With Bovine Serum Albumin: Spectroscopy, Antioxidant Activity, LC-MS, and Molecular Docking Approach.
咖啡酰奎宁酸与牛血清白蛋白相互作用的研究:光谱学、抗氧化活性、液相色谱 - 质谱联用及分子对接方法
Front Chem. 2019 Dec 6;7:840. doi: 10.3389/fchem.2019.00840. eCollection 2019.